CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Revenues	$ 167	$ 62	$ 431	$ 388
Cost of revenue	5	1	105	115
Gross profit	162	61	326	273
Operating expenses
Selling, general and administrative	1,807	1,822	6,219	7,035
Research and development cost	303	187	1,067	1,100
Operating Expenses, Total	2,110	2,009	7,286	8,135
Operating loss	(1,948)	(1,948)	(6,960)	(7,862)
Interest and other income/(expense), net	0	(27)	32	0
Provision for loan receivable - related party	0	(1,711)	0	(1,711)
Gain on sale of loan receivable - related party			81	0
Net loss from continuing operations before income tax benefit	(1,948)	(3,686)	(6,847)	(9,573)
Income tax benefit	0	0	51	167
Net loss from continuing operations before non-controlling interest			(6,796)	(9,406)
Discontinued operations
Net loss from operations of Medicexchange, net of income tax benefit			0	(234)
Gain on sale of Medicexchange, net of income taxes			0	149
Income (Loss) from Operations before Extraordinary Items, Total			0	(85)
Net loss before non-controlling interest	(1,948)	(3,686)	(6,796)	(9,491)
Net loss attributable to non-controlling interest	746	854	2,652	2,639
Net loss attributable to MGT Capital Investments, Inc.	$ (1,202)	$ (2,832)	$ (4,144)	$ (6,852)
Per share data:
Basic and diluted loss per share from continuing operations (in dollars per share)	$ (0.03)	$ (0.09)	$ (0.11)	$ (0.20)
Basic and diluted loss per share from discontinued operations (in dollars per share)			$ 0	$ (0.01)
Earnings Per Share, Basic and Diluted (in dollars per share)	$ (0.03)	$ (0.09)	$ (0.11)	$ (0.21)
Weighted average number of common shares outstanding (in shares)	39,092,257	32,550,590	39,064,683	32,550,590